Efficacy of a novel BCL-XL degrader, DT2216, in preclinical models of post-myeloproliferative neoplasm secondary AML Meeting Abstract
| Authors: | Wang, Z.; Skwarska, A.; Poigailwar, G.; Chaudhry, S.; Rodriguez-Meira, A.; Sui, P.; Olivier, E.; Jia, Y.; Ramage, C. L.; Zheng, G.; Schurer, A.; Gritsman, K.; Papapetrou, E.; Bhalla, K. N.; Zhou, D.; Mead, A. J.; Rampal, R.; Tyner, J. W.; Abbas, H. A.; Pemmaraju, N.; Tatarata, Q. Z.; Konopleva, M. |
| Abstract Title: | Efficacy of a novel BCL-XL degrader, DT2216, in preclinical models of post-myeloproliferative neoplasm secondary AML |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 2749 |
| End Page: | 2751 |
| Language: | English |
| ACCESSION: | WOS:001412581300038 |
| DOI: | 10.1182/blood-2024-194031 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Hybrid event -- Source: Wos |
